Abstract Objective To evaluate the clinical effect of endotracheal lavage with porcine pulmonary surfactant (PS) in term neonates with severe meconium aspiration syndrome (MAS). Methods A total of 136 full-term infants with severe MAS who were admitted to the neonatal intensive care unit between January 2010 and June 2013 were randomly and equally divided into PS lavage and PS injection groups. In the PS lavage group, patients were treated with endotracheal lavage using 3-5 mL of diluted PS (12 mg/mL) each time, and the PS injection group was given PS by intratracheal injection at the first dose of 200 mg/kg. Blood gas, oxygenation index (OI), and PaO2/FiO2 (P/F) of the two groups were evaluated before and 2, 12, 24, and 48 hours after the treatment, and the duration of mechanical ventilation, complication rate, and cure rate were compared between the two groups. Results Compared with the PS injection group, the PS lavage group had significantly higher PaO2 and P/F ration and significantly lower PaCO2 and OI at 12, 24, and 48 hours post-treatment (PPPPPConclusions Compared with the intratracheal injection of PS, endotracheal lavage with diluted PS in term neonates with severe MAS can increase ventilation and oxygenation efficiency, shorten the duration of mechanical ventilation, reduce the complication rate, and increase the cure rate, indicating that this method is a safe and effective therapeutic strategy.
LIN Xin-Zhu,LAI Ji-Dong,LAN Zhao-Yang et al. Clinical effect of endotracheal lavage with porcine pulmonary surfactant in term neonates with severe meconium aspiration syndrome[J]. CJCP, 2014, 16(7): 709-713.
LIN Xin-Zhu,LAI Ji-Dong,LAN Zhao-Yang et al. Clinical effect of endotracheal lavage with porcine pulmonary surfactant in term neonates with severe meconium aspiration syndrome[J]. CJCP, 2014, 16(7): 709-713.
Chinese Collaborative Study Group for Neonatal Rspiratory Diseases. Treatment of severe meconium aspiration with porcine surfactant: a multicentre, randomized, controlled trial[J]. Acta Paediatrica, 2005, 94(7): 896-902.
[8]
Ohana Y, Ogawa Y. Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model[J]. Pediatr Pulmonol, 1999, 28(1): 18-23.
3.0.CO;2-O target="_blank">
[9]
Lan BC, Yeung CY. Surfactant lavage for meconium aspiration syndrome a pilot study[J]. Pediatrics, 1999, 103(10): 1014-1018.
[10]
Cochrane CG, Revak SD, Merritt TA. Bronchial lavage with KL4-surfactant in models of meconium aspiration syndrome[J]. Pediatr Res, 1998, 44(6): 705-715.
[11]
Dargaville PA, Mills JF, Hendley BM. Therapeutic lung lavage in the piglet model of meconium aspiration syndrome[J]. Am J Respir Crit Care Med, 2003, 168(4): 456-463.
Wiswell TE, Knight GR, Finer NN. A multicenter randomized controlled trial comparing surfaxin(Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome[J]. Pediatrics, 2002, 109(10): 1081-1087.
